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Uses of Lactobacillus species have attracted much attention as probiotics due to their
natural occurrence in the human gastrointestinal system. As a probiotic, Lactobacillus
acidophilus is important in the dairy and nutraceutical industries due to its application in
the maintenance of human and animal health. Probiotics are live microbial supplements
that provide many benefits to human health such as favorably alter the intestinal mi-
cro-flora balance, inhibit the growth of harmful bacteria, promote good digestion, boost
immune function, prevent and treat atopic and allergic diseases, lower blood cholesterol
levels, exert anticancer effects, prevent symptoms of lactose intolerance and increase re-
sistance to infection (1, 2). Probiotic bacteria maintain a healthy balance of intestinal flora
by producing compounds such as organic acids and hydrogen peroxide that increase in-
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In the present study, a capsule formulation composed of
enteric coated granules of Lactobacillus acidophilus ATCC
4962 was developed using Eudragit L30D-55 as enteric
polymer. Optimization of the capsule formulation was
achieved with a maximum viable cell count after 2 h of
incubation in acid medium and disintegration time of 1 h
in buffer pH 6.8. The amount of Eudragit L30D-55 in the
capsules correlated with gastric juice resistance. The best
protective qualities against artificial gastric juice were ob-
served when capsules were prepared from granules com-
posed of L. acidophilus, corn starch, lactose monohydrate,
polyvinylpyrrolidone and coated with 12.5 % (m/V) of
Eudragit L30D-55. Capsule formulation of L. acidophilus
in edible broth medium suspension serves as a cheap al-
ternative to the expensive freeze-drying procedure for pre-
paring L. acidophilus. In addition, the enteric coating us-
ing Eudragit L30D-55 could protect probiotics from the
acidic gastric environment and enhance the bioactivity
of probiotics along with replacement of pathogenic mi-
crobes in human intestine.
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testinal acidity and inhibit reproduction of numerous harmful bacteria. In addition, they
also produce substances called bacteriocins, which act as natural antibiotics destroying
undesirable microorganisms (3).
Wet granulation is a size enlargement process in which a liquid is used to achieve
agglomeration of solid particles in a formulation (4). This granulation method affects the
physical properties of granules, such as size, hardness, density and porosity. This also
influences the reproducibility of preparations by affecting granular flowability, compres-
sibility of powders, disintegration time and dissolution rate (5). Granulation parameters
must be controlled to ensure the manufacture of granules with the desired particle size
(6). Further, enteric coating is aimed at protecting the formulations from gastric fluid in
the stomach and consequent release in the intestinal region (7). Probiotics have been pre-
pared as dietary supplements in the form of tablets, capsules and freeze-dried prepara-
tions (8), but the expense of freeze-drying is a distinct disadvantage. Use of edible me-
dium would bypass the use of the freeze-drying procedure (which is expensive) and allow
direct mixing of the bacteria and metabolites to form granules. In this research, poly-
mers were used with an intention to protect L. acidophilus ATCC 4962 against the harm-
ful effects of gastric acidity and in order to ensure its viability and safe release at the tar-
get, i.e., intestine. Hence, the main objective was to evaluate the suitability of available
coating polymers for enteric-coating of granules containing L. acidophilus ATCC 4962.
EXPERIMENTAL
Bacterial culture and growth conditions
Lactobacillus acidophilus ATCC 4962 was purchased from the American Type Culture
Collection (USA). The culture was stabbed in De-Man Rogosa Sharpe Agar (MRSA) me-
dium (Difco, USA) and stored at 4 °C. The strain was activated by two subcultures in
100 mL MRS broth prior to experimental use.
Cultivation of L. acidophilus in edible broth medium with skim milk
Food-grade broth medium was prepared according to Pyar and Peh (9). The food-
-grade broth medium (per liter of distilled water) contained 5.0 g peptone water (Oxoid,
UK), 5.0 g yeast extract (Fluka, Germany), 0.5 g bile salts (Sigma-Aldrich, Germany), 0.5
g L-cystine HCl (Fluka, Switzerland), 2.0 g NaHCO3 (R & M Chemicals, UK), 0.1 g NaCl
(Sigma-Aldrich, USA), 0.01 g CaCl2·2H2O (Merck, Germany), 0.01 g MgSO4 × 7 H2O (AJAX
Chemicals, Australia), 0.04 g K2HPO4 (Merck, Germany) and 20.0 g glucose (R & M Che-
micals, UK). The medium was prepared by suspending all ingredients in 1.0 L of dis-
tilled water and boiling it until the ingredients were completely dissolved. The pH of the
mixture was adjusted with 1 mol L–1 HCl to 6.0 ± 0.1. The mixture was autoclaved at 121
°C for 15 min and cooled to 45 °C prior to use. Skim milk powder (Sunlac, New Zea-
land), at concentrations of 0.5, 0.8, 1.0, 1.2, 1.6, 1.8, 2.0, 2.2, 2.5, 2.7 and 3.0 % (m/V), was
added to edible broth medium. L. acidophilus ATCC 4962 was cultivated for 36 h at 37 °C
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at an agitation speed of 100 rpm. A 1 mL sample was taken from each flask, followed by
serial dilution before the number of colonies was counted using the pour plate method.
The plates were then incubated at 37 °C for 72 h and viable counts of each concentration
were obtained.
Preparation of L. acidophilus granules in edible broth medium with skim milk
Microcrystalline cellulose (Asahi Chemical Industry, Japan), lactose monohydrate
impalpable grade (HMS, Holland) and corn starch (Euro Chemo, China) were first siev-
ed through a 300 µm diameter sieve (Endecotts, UK) to break up lumps. 2 % (m/m) po-
vidone water solution (ISP Technology, USA) was added as a binder. All these materials
were blended in a planetary mixer (Kenwood, UK) for 5 min. Three different volumes of
edible broth medium containing L. acidophilus ATCC 4962 and 2.0 % (m/V) skim milk
were mixed with the powder mass for 10 min. Different formulations of L. acidophilus
ATCC 4962 granules were prepared as shown in Table I. The wet mass was screened
through a 1.70 mm diameter sieve (Endecotts, UK) and dried in an oven (Memert, Ger-
many) at 38 ± 2 °C for about 18 h until constant weight was reached. Dried granules
were screened through a 1.00 mm diameter sieve (Endecotts, UK). Finally, magnesium
stearate (Uitgest, Holland) at a concentration (1 %, m/m) and aerosil (Uitgest, Holland) at
a concentration (0.5 %, m/m) were added and mixed with the granules. Granules within
a size range of 0.71–1.00 mm diameter were used in capsule preparation.
Characterization of formulations
The parameters studied to characterize the formulations were, bulk density, tap den-
sity, moisture content, compressibility, flowability and viable count.
Bulk and tapped densities. – Bulk density (r) was calculated by measuring the mass (m)
per unit volume of granules (V). The mass of the volume was recorded and the corre-
sponding volume of granules was measured using a graduated measuring cylinder. For
tapped density measurement, the granules were tapped 200 times, which was sufficient
for the granules to reach a constant volume using graduated glass measuring cylinders
(10).
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Table I. Formulations of granules containing L. acidophilus ATCC 4962 in edible broth medium
Ingredient
Formulation
F(1) F(2) F(3)
L. acidophilus and 2 % (m/V) skim milk
in edible broth medium (mL)
Corn starch (g)
Lactose monohydrate (g)
Povidone (g)
Microcrystalline cellulose (g)
35
30
38
2
30
52
25
35
2
38
65
25
25
2
48
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Carr’s compressibility index. – Carr’s index was calculated from bulk and tapped den-
sities using the following equation (11):
Carr’s Index (%) =
r r
r
f i
f
−
´ 100 % (1)
where: rf is tapped density and ri is the bulk density.
Moisture content measurement. – The moisture content of granules for the different
formulations was monitored and measured using an infra-red moisture analyzer (Mett-
ler Toledo Delta range, PM 480, Switzerland). Five grams of powder was heated for 10
min at 105 °C and reweighed (12).
Flowability test. – Carr’s compressibility index is widely used as a marker of powder
flowability (13). Therefore, Carr’s compressibility index was calculated in the present
study.
Total viable count. – To determine the viable count of L. acidophilus ATCC 4962 pres-
ent in the granules, 1 g of granules was rehydrated with 9 mL of food-grade broth me-
dium and the suspension was serially diluted with broth medium (14). Serial dilutions
of the L. acidophilus ATCC 4962 suspension were incubated aerobically at 37 ± 1 °C for 72 h
in food-grade agar medium, and viable count was determined by the pour plate method
using a colony counter (Technical Lab Instrument, USA).
Enteric coating of granules
To achieve suitable processing conditions for the top-spray fluidized bed coater in
granule coating (Uni-Glatt, Germany), different coating parameters were optimized, such
as inlet temperature, fluidization, air flow rate, atomizer pressure and spray rate, using
one-at-a-time strategy by varying one parameter each time while keeping the others
constant. Various inlet temperatures were studied. By accurate control of temperature,
the optimum temperature between the granule drying time and viable bacterial cell count
was selected.
Optimum temperature was then fixed and different fluidized air flow rates were se-
lected to optimize the flow rate. The best fluidized air flow rate was fixed and the pres-
sure was optimized. Further, two spray rates were tested after fixing all the other param-
eters and the spray rate that assured little formation of agglomerates was selected. A
batch of 200 g of granules (F3) was allowed to fluidize in the coating chamber until the
inlet air temperature reached the required temperature. The granules were coated with
100 mL aqueous coating solution containing Eudragit L30D-55 (Pharma Polymer, Ger-
many), at concentrations 5.0, 7.5, 10.0, 12.5 and 15.0 % (m/V), plasticized with 5 % (V/V)
of triethylcitrate (Merck, Germany). Coated granules were allowed to fluidize for 10 min
to ensure complete drying after spraying. Coated granules of 500 mg were then filled
manually into hard gelatin capsules (Halagel (M), Malaysia) of size zero.
In vitro dissolution studies
The in vitro dissolutions of L. acidophilus ATCC 4962 capsules were studied under
simulated gastric and intestinal fluids. Simulated gastric fluid and intestinal fluid were
prepared according to the method described in the United States Pharmacopoeia (28).
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Artificial gastric juice was prepared by dissolving 2.0 g of sodium chloride and 3.2 g
of purified pepsin (pepsin is derived from porcine stomach mucosa, with an activity of
800 to 2500 units per mg of protein) (Sigma, Germany) in 7.0 mL of hydrochloric acid
and sufficient water to 1000 mL. The pH of the solution was 1.1–1.2.
Artificial gastric juice was studied to evaluate resistance against acidic conditions at a
temperature of 37 °C for 1 or 2 h of incubation using a dissolution tester (apparatus 2, USP
XXIV). To evaluate the gastric juice resistance, capsules were incubated at 37 °C for 1 or 2
h and the differences of microbial cell counts were determined (15).
Simulated intestinal fluid was prepared by dissolving 6.8 g of monobasic potassium
phosphate (Merck, Germany) in 250 mL of water, which was mixed and 77 mL of 0.2 mol
L–1 sodium hydroxide (R & M Chemicals, UK) and 500 mL of water were added. 10.0 g of
pancreatin (Sigma, Germany) was added and topped up with water to 1000 mL. The re-
sulting solution was adjusted with 0.2 mol L–1 sodium hydroxide to pH of 6.8 ±0.1 (16).
The dissolution study was performed according to the USP dissolution test appara-
tus II paddle method (model PT-DT7, Pharma Test Apparatebau GmbH, Germany). 900
mL of dissolution medium was maintained at 37.0 ± 0.5 °C and the rotation speed was
set at 100 rpm. A 5 mL sample was withdrawn after 2 h and the release of L. acidophilus
ATCC 4962 from the capsule in dissolution medium (simulated intestinal fluid) was esti-
mated using the pour plate method. The test was run in triplicate.
Statistical analysis
The results were treated statistically using SPSS software (version 13.0, USA). Stu-
dent’s independent t-test and one-way analysis of variance were used to analyze the re-
sults. When there was a statistically significant difference, a post-hoc Tukey’s honestly
significant difference test was used. A statistically significant difference was considered
when p < 0.05.
RESULTS AND DISCUSSION
Growth of L. acidophilus in edible broth medium with skim milk
Skim milk has been used as a growth medium for L. acidophilus (17). L. acidophilus
requires different amino acids to grow. These amino acids are present in skim milk but
they alone are not sufficient to support maximum growth rates (18). Combination of skim
milk (contains amino acids) with edible broth medium containing glucose (the carbohy-
drate source), yeast extract (the nitrogen source) and minerals stimulates the growth of
L. acidophilus (19). The profile of growth and viable counts of L. acidophilus ATCC 4962
are shown in Fig. 1. Viable counts increased by increasing the concentration of skim milk
and reached a maximum of 9.73 log cfu mL–1 at a 2.0 % concentration. The results of via-
ble counts for different skim milk concentrations were statistically significant (p < 0.05).
There was no significant difference with a further increase from 2.0 to 2.2 % (p > 0.05).
Above 2.2 %, there was a significant decline in viable counts. The increase in viable counts
of bacteria with an increase in skim milk concentration was obviously due to the larger
supply of amino acids to sustain and enhance the growth of bacterial cells. Reduction in
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the growth rate with further increase in skim milk concentration beyond the optimum
2.2 % was possibly due to the osmotic effects, which could have killed the bacteria.
Characterization of different formulation types
The results of bulk density, tapped density, moisture content, compressibility, flow-
ability and viable counts of different L. acidophilus ATCC 4962 formulations are shown in
Table II. Interparticulate interactions correlate with the powder flow and a comparison
of bulk and tapped densities. Comparison between bulk and tapped densities was often
used as an index of the ability of powder to flow, such as Carr’s compressibility index or
the Hausner ratio (20). The results of bulk and tapped densities of the granules provide
useful information about the volume of the final dosage form and can affect the dosing
of the final granules into final capsules (21).
Carr’s index measures the flow properties of powders; the smaller is Carr’s index,
the better are the flow properties. Powders that form hard compacts under applied pres-
sure without exhibiting any tendency to capping or chipping can be considered com-
pressible. Carr’s index between 5–15 % indicates excellent flowability of the granules (22).
Carr’s index obtained for all the formulations was between 5.08 and 9.37 % and there-
fore the flow properties of the granules were excellent.
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Fig. 1. Viable count of L. acidophilus in edible broth with skim milk. Results are expressed as
mean ± SD; each data point is the average of three independent replicated measurements, n = 3.
Table II. Characterization of different Bacillus acidophilus ATCC 4962 formulations
Parametersa
Formulations
F(1) F(2) F(3)
Bulk density (g mL–1) 0.448 0.482 0.47
Tap density (g mL–1) 0.476 0.511 0.510
Moisture content (%) 1.97 ± 0.14 1.87 ± 0.13 1.92 ± 0.28
Carr’s index (%) 6.0 5.78 8.01
Flowability Excellent Excellent Excellent
Viable count (cfu/g) 9.23 ± 0.01 9.43 ± 0.05 9.51 ± 0.02
a Mean ± SD, n = 3.
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Moisture content is a critical parameter for the granulation process with optimum
binding force. As the moisture content of a powder increases, adhesion and cohesion
tend to increase (23). Granules having a moisture content above the critical range affect
the frictional properties and become sticky and hard. The moisture content results of all
formulations investigated in this study were within the acceptable range (1.87–1.97 %).
According to the literature, the acceptable limit for moisture content is between 0.7 and
2.0 % (24).
Viable counts were conducted for all the L. acidophilus ATCC 4962 formulations. Results
of all the L. acidophilus ATCC 4962 formulations were above 9.0 log cfu/500 mg, which is
sufficient for the humans (25). Formulation F (3) was selected for enteric coating.
Coating process and capsulation of granules
Enteric coating is important to protect L. acidophilus ATCC 4962 against the highly
acidic environment in the stomach (26). To optimize and achieve suitable coating conditi-
ons, a series of experiments were carried out using granules with L. acidophilus ATCC 4962.
The coating parameters, which included the inlet air temperature, fluidized air flow
rate, atomizer pressure and spray rate, were critical during optimization, since these pa-
rameters could affect the viability of probiotics during coating (27). Observations obtain-
ed in the optimization of coating parameters are summarized in Table III.
The selected formulation (F3) was coated successfully using Eudragit L30D-55, which
ensured that the oral dosage form would pass through the stomach without release and
deliver the drug into the small intestine (28).
To improve the plasticity of granules, triethyl citrate was introduced into the coat-
ing. This plasticizer does not only affect the film formation process by lowering the glass
transition temperature but also the film properties such as water vapor transmission and
accelerated drug release by leaching into the dissolution medium creating pathways for
drug diffusion (release of probiotics) (29).
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Table III. Evaluation of coating parameters
Parameter Condition Observation
Inlet temperature
(°C)
50–60 reduced viable bacterial cell count
28–30 granules agglomerated
36–38 granules dried and enhanced viable bacterial cell count
Fluidizing air flow
rate
(m3 h–1)
120–140 granules fragmented
90–110 good fluidization
60–80 granules could not be fluidized
Atomizing air
(bar)
1.4 granules became powdery
1.0 good fluidization
0.8 agglomeration occurred
Spray rate
(mL min–1)
1.5 agglomeration occurred
1.0 no agglomeration
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In vitro release studies
The in vitro release results of L. acidophilus ATCC 4962 coated with different levels of
Eudragit L30D-55 are shown in Table IV. Formulation F(3) showed release at the coating
level below 7.5 % and no release at the coating level of 7.5 % and above. The coating
level below 7.5 % was not sufficient to protect L. acidophilus ATCC 4962 from the highly
acidic stomach environment. The lower enteric coating level required by formulation
F(3) could be attributed to the presence of higher content of skim milk and the use of
skim milk that was not exposed to freeze drying. However, it was observed that once
formulation F(3) was in simulated intestinal fluid, L. acidophilus ATCC 4962 was readily
released, with the dissolution of the enteric coat under the alkali pH environment. Num-
bers of viable counts of L. acidophilus ATCC 4962 at 12.5 and 15 % (m/V) Eudragit L30D-55
coating were found to be more or less equal (9.1 log cfu/cap). Therefore, no significant
difference was observed between the two different concentrations of coating. This coat-
ing level would be critical to ensure that probiotics survived during their passage through
the human gastrointestinal tract and reached the small intestine as viable organisms for
potential health effects (30). In the present study, the addition of Eudragit L30D-55 was es-
sential to guarantee protection against gastric juice. The preparation demonstrated resis-
tance to gastric juice, which enabled the delivery of approximately 109 viable probiotic
bacteria to the intestine within 1–2 h. These results are in agreement with other research-
ers who found that effects of L. acidophilus were very beneficial when colonizing the hu-
man intestine at doses of 106 cfu and above and replacing proteolytic microbes.
CONCLUSIONS
It can be concluded from the present work that the probiotic L. acidophilus ATCC
4962 can be incorporated directly into the preparation of granules without the laborious
process of freeze-drying. Enteric coating of the granules using Eudragit L30D-55 pro-
tected the release of L. acidophilus ATCC 4962 in acidic media. In contrast, the release of
these bacteria from capsules was shown to be very prompt in alkyl pH. It is believed
that the coating of granules with enteric polymers would protect the probiotic from the
acidic environment and improve the survival rate of the microorganism also in human
intestine.
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Table IV. Lactobacillus acidophilus ATCC 4962 release in simulated gastric fluid
Formulation
Coating level
(%)
Viable count
5.0 3.83 log CFU/cap
F(3) 7.5 no growth
10.0 no growth
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